Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study

Giovanni Triolo, Nicola Francesca

Risultato della ricerca: Other

Lingua originaleUndefined/Unknown
Pagine871-871
Stato di pubblicazionePublished - 2006

Cita questo

Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study. / Triolo, Giovanni; Francesca, Nicola.

2006. 871-871.

Risultato della ricerca: Other

Triolo, G & Francesca, N 2006, 'Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study', pagg. 871-871.
Triolo G, Francesca N. Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study. 2006.
Triolo, Giovanni ; Francesca, Nicola. / Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study.
@conference{40b21d1f6e2040a0b8e87449ff95234a,
title = "Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study",
author = "Giovanni Triolo and Nicola Francesca",
year = "2006",
language = "Undefined/Unknown",
pages = "871--871",

}

TY - CONF

T1 - Indirect Cost of Rheumatoid Arthritis Before and After Successful Initiation of Treatment With Biological Anti-TNFα Drugs: The GISEA Study

AU - Triolo, Giovanni

AU - Francesca, Nicola

PY - 2006

Y1 - 2006

UR - http://hdl.handle.net/10447/14033

M3 - Other

SP - 871

EP - 871

ER -

Accesso al documento